30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: Integra LifeSciences

$72.9MM, -3%

  • U.S. Extremities $31.9MM, +2%
  • U.S. Spine & Other $41.0MM, -6% (U.S. Spine -7%)

 

  • Extremities impacted somewhat by weather
  • U.S. Spine decline entirely in hardware; biologics grew in mid-single-digits
  • Increasing new distribution for spine portfolio
  • Price pressure by product: biologics “a point or two,” spine hardware 4%-5%, extremities: regenerative minimal pressure, metal “a point or two”